Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Benoit-Vical

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Malaria Journal|February 16, 2012
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparumAurélie Pascual, Philippe Parola, Françoise Benoit-Vical, et al.
Pathogens (Basel, Switzerland)|June 26, 2024
Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks"Ange W Embo-Ibouanga, Michel Nguyen, Jean-Patrick Joly, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
Correction: Embo-Ibouanga et al. Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks". <i>Pathogens</i> 2024, <i>13</i>, 482Ange W Embo-Ibouanga, Michel Nguyen, Jean-Patrick Joly, et al.
European Journal of Immunology|April 27, 2007
IL-13 induces expression of CD36 in human monocytes through PPARgamma activationAntoine Berry, Patricia Balard, Agnès Coste, et al.
Molecules (Basel, Switzerland)|March 28, 2024
Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial DrugsAnge W Embo-Ibouanga, Michel Nguyen, Lucie Paloque, et al.
Plos One|July 26, 2017
Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malariaSokhna Keita Alassane, Marie-Laure Nicolau-Travers, Sandie Menard, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of <i>Plasmodium falciparum</i>Dyhia Amrane, Christophe-Sébastien Arnold, Sébastien Hutter, et al.
Molecules (Basel, Switzerland)|August 28, 2020
Alkoxyamines Designed as Potential Drugs against <i>Plasmodium</i> and <i>Schistosoma</i> ParasitesThibaud Reyser, Tung H To, Chinedu Egwu, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2012
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western CambodiaBenoit Witkowski, Nimol Khim, Pheaktra Chim, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Malaria Journal|February 16, 2012
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparumAurélie Pascual, Philippe Parola, Françoise Benoit-Vical, et al.
Pathogens (Basel, Switzerland)|June 26, 2024
Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks"Ange W Embo-Ibouanga, Michel Nguyen, Jean-Patrick Joly, et al.
Pathogens (Basel, Switzerland)|July 30, 2025
Correction: Embo-Ibouanga et al. Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks". <i>Pathogens</i> 2024, <i>13</i>, 482Ange W Embo-Ibouanga, Michel Nguyen, Jean-Patrick Joly, et al.
European Journal of Immunology|April 27, 2007
IL-13 induces expression of CD36 in human monocytes through PPARgamma activationAntoine Berry, Patricia Balard, Agnès Coste, et al.
Molecules (Basel, Switzerland)|March 28, 2024
Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial DrugsAnge W Embo-Ibouanga, Michel Nguyen, Lucie Paloque, et al.
Plos One|July 26, 2017
Young Sprague Dawley rats infected by Plasmodium berghei: A relevant experimental model to study cerebral malariaSokhna Keita Alassane, Marie-Laure Nicolau-Travers, Sandie Menard, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of <i>Plasmodium falciparum</i>Dyhia Amrane, Christophe-Sébastien Arnold, Sébastien Hutter, et al.
Molecules (Basel, Switzerland)|August 28, 2020
Alkoxyamines Designed as Potential Drugs against <i>Plasmodium</i> and <i>Schistosoma</i> ParasitesThibaud Reyser, Tung H To, Chinedu Egwu, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2012
Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western CambodiaBenoit Witkowski, Nimol Khim, Pheaktra Chim, et al.
Pageof 9